© Copyright Nostre Net
Facial paralysis is a restriction of the
facial movement due to nerve damage. Facial nerve paralysis is characterized by
unilateral facial weakness. Some other symptoms include loss of taste,
hyperacusis, and decreased salivation and tear secretion.
Asia Pacific is the fastest growing market
for facial paralysis whose growth is attributed to the rising population and
increasing standard of living. Additionally, the increasing healthcare spending
and the improved standard of living are likely to drive the growth of the
market. India and China are the major contributors to the market growth due to
the rapid development of healthcare infrastructure in these regions and the
increasing demand for diagnostic services.
The global facial
paralysis market Trends is expected to register a CAGR of 6.5% during the
forecast period.
Key Players
Some of the key players in the facial
paralysis market are, Boston Scientific, BioControl Medical, Cerebomed,
Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis
AG, among others.
On the other hand, the Middle East and
Africa is expected to witness a gentle growth due to limited access to the
healthcare industry and affordability issues among the population. In the
Middle East, the growth of the market is driven by the increasing availability of
new and advanced diagnostic and treatment methods for various chronic diseases.
Segmentation
The global facial paralysis market is
segmented on the basis of treatment, diagnosis, type, and end-user.
On the basis of type, the market is
segmented into, Ramsay Hunt Syndrome, facial erythema, Bell’s Palsy, and Lyme
Disease.
On the basis of diagnosis, the market is
segmented into electromyography, computerized tomography, and magnetic
resonance imaging.
On the basis of treatment, the market
is segmented into medications, physical therapy, and surgery.
On the basis of medication, the
market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is
segmented into hospitals and clinics, specialty centers, and research centers.
Regional Analysis
The Americas dominates the global facial
paralysis market Research Report owing to increasing cardiovascular
disorders, which eventually leads to the increasing patient population.
Additionally, increasing cardiovascular disorder rate is likely to enhance the
growth of facial paralysis in the North American region. According to the
American Heart Association, 31% of the deaths in the U.S. were due to
cardiovascular disorders. Similarly, in 2015, around USD 3.2 trillion were
spend in healthcare expenditure in the U.S according to the Center for Disease
Control and Prevention. Similarly, in 2015, 1.3% of the U.S. adults were
diagnosed with inflammation of facial nerves.
Europe accounts for the second largest
market due to increasing cardiovascular disorders and increasing infections.
Additionally, the increasing government support and improving healthcare infrastructure
along with increasing facial inflammations are driving the growth of the facial
paralysis market in Europe. For instance, Eurostat estimated that over 19.2% of
the population in Europe was aged 65 and above. This increasing older
population is likely to lead to the increasing patient population. These
factors are likely to drive the growth of the facial paralysis market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Wall